Gary J. Vora

TL;DR: Successful proof-of-concept experiments demonstrate the ability of this approach for correct species- and strain-level identification with unambiguous statistical interpretation at clinically relevant sensitivity levels, and underscore the feasibility of using this approach to expedite the early surveillance of diseases, and provide new information on the incidence of multiple pathogens.

TL;DR: These findings correct a number of species misidentifications while validating the ability of both CGH and MLSA to distinguish closely related members of the Harveyi clade.

TL;DR: The results presented here underscore the feasibility of using random amplification approaches and begin to systematically address the versatility of these approaches for unbiased pathogen detection from environmental sources.

TL;DR: A single multiplex PCR assay to simultaneously amplify 95 diagnostic regions and combined it with a long oligonucleotide microarray to create a platform capable of rapidly detecting and discriminating the major human pathogenic species from the genus Vibrio is designed.

TL;DR: These viral nanoparticles markedly increased assay sensitivity in a microarray-based genotyping assay for Vibrio cholerae O139, thus demonstrating their applicability for existing DNA microarray protocols.